Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 676 AL 690

Land Plus Aquatic Therapy Versus Land-Based Rehabilitation Alone for the Treatment of Freezing of Gait in Parkinson Disease: A Randomized Controlled Trial

Clerici I, Maestri R, Bonetti F, Ortelli P, Volpe D, Ferrazzoli D, Frazzitta G.

Phys Ther. 2019 May 1;99(5):591-600. doi: 10.1093/ptj/pzz003.

Chronotherapies for Parkinson's disease

Fifel K, Videnovic A.

Prog Neurobiol. 2019 Mar;174:16-27. doi: 10.1016/j.pneurobio.2019.01.002. Epub 2019 Jan 15.

Gut microbiota in neurodegenerative disorders

Roy Sarkar S, Banerjee S.

J Neuroimmunol. 2019 Mar 15;328:98-104. doi: 10.1016/j.jneuroim.2019.01.004. Epub 2019 Jan 9.

Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial

Elder GJ, Colloby SJ, Firbank MJ, McKeith IG, Taylor JP.

Alzheimers Res Ther. 2019 Jan 18;11(1):9. doi: 10.1186/s13195-018-0465-9.

Fishing for Parkinson's Disease: A review of the literature

Ünal İ, Emekli-Alturfan E.

J Clin Neurosci. 2019 Apr;62:1-6. doi: 10.1016/j.jocn.2019.01.015. Epub 2019 Jan 16.

Contributions of VPS35 Mutations to Parkinson's Disease

Rahman AA, Morrison BE.

Neuroscience. 2019 Mar 1;401:1-10. doi: 10.1016/j.neuroscience.2019.01.006. Epub 2019 Jan 18.

Suicide in Parkinson's disease

Shepard MD, Perepezko K, Broen MPG, Hinkle JT, Butala A, Mills KA, Nanavati J, Fischer NM, Nestadt P, Pontone G.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):822-829. doi: 10.1136/jnnp-2018-319815. Epub 2019 Jan 19.

Progress of Pharmacological Approaches in Parkinson's Disease

Zeuner KE, Schäffer E, Hopfner F, Brüggemann N, Berg D.

Clin Pharmacol Ther. 2019 May;105(5):1106-1120. doi: 10.1002/cpt.1374. Epub 2019 Mar 22.

The next chapter in symptomatic Parkinson disease treatments

Hengartner D, Fernandez HH.

Parkinsonism Relat Disord. 2019 Feb;59:39-48. doi: 10.1016/j.parkreldis.2019.01.002. Epub 2019 Jan 3.

APT-weighted MRI: Techniques, current neuro applications, and challenging issues

Zhou J, Heo HY, Knutsson L, van Zijl PCM, Jiang S.

J Magn Reson Imaging. 2019 Aug;50(2):347-364. doi: 10.1002/jmri.26645. Epub 2019 Jan 20.

Going beyond the mean: Intraindividual variability of cognitive performance in prodromal and early neurodegenerative disorders

Costa AS, Dogan I, Schulz JB, Reetz K.

Clin Neuropsychol. 2019 Feb;33(2):369-389. doi: 10.1080/13854046.2018.1533587. Epub 2019 Jan 21.

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

LeWitt PA, Hauser RA, Pahwa R, Isaacson SH, Fernandez HH, Lew M, Saint-Hilaire M, Pourcher E, Lopez-Manzanares L, Waters C, Rudzínska M, Sedkov A, Batycky R, Oh C; SPAN-PD Study Investigators.

Lancet Neurol. 2019 Feb;18(2):145-154. doi: 10.1016/S1474-4422(18)30405-8.

Exosomes in Parkinson's Disease: Current Perspectives and Future Challenges

Yuan L, Li JY.

ACS Chem Neurosci. 2019 Feb 20;10(2):964-972. doi: 10.1021/acschemneuro.8b00469. Epub 2019 Feb 1.

Fusion of WPT and MFCC feature extraction in Parkinson's disease diagnosis

Kuresan H, Samiappan D, Masunda S.

Technol Health Care. 2019;27(4):363-372. doi: 10.3233/THC-181306.

Cannabinoid receptor as a potential therapeutic target for Parkinson's Disease

Baul HS, Manikandan C, Sen D.

Brain Res Bull. 2019 Mar;146:244-252. doi: 10.1016/j.brainresbull.2019.01.016. Epub 2019 Jan 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias